Maternal serum α-fetoprotein screening for chromosomal abnormalities: A prospective study in women aged 35 and older
- 1 April 1994
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 170 (4) , 1073-1080
- https://doi.org/10.1016/s0002-9378(94)70100-8
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Prenatal Screening for Down's Syndrome with Use of Maternal Serum MarkersNew England Journal of Medicine, 1992
- Antenatal maternal serum screening for Down's syndrome: results of a demonstration project.BMJ, 1992
- Estimating the risk of a fetal autosomal trisomy at mid‐trimester using maternal serum alpha fetoprotein and age: A retrospective study of 142 pregnanciesPrenatal Diagnosis, 1991
- Screening for Down's syndrome in older women based on maternal serum alpha-fetoprotein levels and age: Preliminary resultsPrenatal Diagnosis, 1991
- Decisions following the intrauterine diagnosis of sex chromosome aneuploidyAmerican Journal of Medical Genetics, 1989
- Maternal serum screening for Down's syndrome in early pregnancy.BMJ, 1988
- Screening for Fetal Down's Syndrome in Pregnancy by Measuring Maternal Serum Alpha-Fetoprotein LevelsNew England Journal of Medicine, 1987
- Parental decisions regarding termination of pregnancy following prenatal detection of sex chromosome abnormalityPrenatal Diagnosis, 1987
- Maternal age specific rates for chromosome aberrations and factors influencing them: Report of a collaborative european study on 52 965 amniocentesesPrenatal Diagnosis, 1984
- Role of Amniocentesis in the Intrauterine Detection of Genetic DisordersNew England Journal of Medicine, 1970